493 related articles for article (PubMed ID: 31412635)
61. High Plasma sRAGE (Soluble Receptor for Advanced Glycation End Products) Is Associated With Slower Carotid Intima-Media Thickness Progression and Lower Risk for First-Time Coronary Events and Mortality.
Grauen Larsen H; Marinkovic G; Nilsson PM; Nilsson J; Engström G; Melander O; Orho-Melander M; Schiopu A
Arterioscler Thromb Vasc Biol; 2019 May; 39(5):925-933. PubMed ID: 30917679
[TBL] [Abstract][Full Text] [Related]
62. Advanced glycation end products (AGEs) on the surface of diabetic erythrocytes bind to the vessel wall via a specific receptor inducing oxidant stress in the vasculature: a link between surface-associated AGEs and diabetic complications.
Wautier JL; Wautier MP; Schmidt AM; Anderson GM; Hori O; Zoukourian C; Capron L; Chappey O; Yan SD; Brett J
Proc Natl Acad Sci U S A; 1994 Aug; 91(16):7742-6. PubMed ID: 8052654
[TBL] [Abstract][Full Text] [Related]
63. Serum AGE/RAGEs as potential biomarker in idiopathic pulmonary fibrosis.
Machahua C; Montes-Worboys A; Planas-Cerezales L; Buendia-Flores R; Molina-Molina M; Vicens-Zygmunt V
Respir Res; 2018 Nov; 19(1):215. PubMed ID: 30409203
[TBL] [Abstract][Full Text] [Related]
64. Circulating Advanced Glycation End Products and Their Soluble Receptors in Relation to All-Cause and Cardiovascular Mortality: A Systematic Review and Meta-analysis of Prospective Observational Studies.
Sharifi-Zahabi E; Sharafabad FH; Abdollahzad H; Malekahmadi M; Rad NB
Adv Nutr; 2021 Dec; 12(6):2157-2171. PubMed ID: 34139010
[TBL] [Abstract][Full Text] [Related]
65. Is there any evidence that AGE/sRAGE is a universal biomarker/risk marker for diseases?
Prasad K
Mol Cell Biochem; 2019 Jan; 451(1-2):139-144. PubMed ID: 29961210
[TBL] [Abstract][Full Text] [Related]
66. The role of advanced glycation end products in vascular aging: which parameter is the most suitable as a biomarker?
Mayer O; Gelžinský J; Seidlerová J; Mateřánková M; Mareš Š; Svobodová V; Trefil L; Cífková R; Filipovský J
J Hum Hypertens; 2021 Mar; 35(3):240-249. PubMed ID: 32203073
[TBL] [Abstract][Full Text] [Related]
67. Endothelial dysfunction in patients with chronic kidney disease results from advanced glycation end products (AGE)-mediated inhibition of endothelial nitric oxide synthase through RAGE activation.
Linden E; Cai W; He JC; Xue C; Li Z; Winston J; Vlassara H; Uribarri J
Clin J Am Soc Nephrol; 2008 May; 3(3):691-8. PubMed ID: 18256374
[TBL] [Abstract][Full Text] [Related]
68. Proteomic study of endothelial dysfunction induced by AGEs and its possible role in diabetic cardiovascular complications.
Banarjee R; Sharma A; Bai S; Deshmukh A; Kulkarni M
J Proteomics; 2018 Sep; 187():69-79. PubMed ID: 29935336
[TBL] [Abstract][Full Text] [Related]
69. Activation of receptor for advanced glycation end products contributes to aortic remodeling and endothelial dysfunction in sinoaortic denervated rats.
Wu F; Feng JZ; Qiu YH; Yu FB; Zhang JZ; Zhou W; Yu F; Wang GK; An LN; Ni FH; Wu H; Zhao XX; Qin YW; Luo HD
Atherosclerosis; 2013 Aug; 229(2):287-94. PubMed ID: 23880178
[TBL] [Abstract][Full Text] [Related]
70. The Role of Advanced Glycation End Products and Its Soluble Receptor in Kidney Diseases.
Steenbeke M; Speeckaert R; Desmedt S; Glorieux G; Delanghe JR; Speeckaert MM
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408796
[TBL] [Abstract][Full Text] [Related]
71. sRAGE and early signs of cardiac target organ damage in mild hypertensives.
Maresca AM; Guasti L; Bozzini S; Mongiardi C; Tandurella N; Corso R; Zerba FG; Squizzato A; Campiotti L; Dentali F; Klersy C; Grandi AM; Falcone C
Cardiovasc Diabetol; 2019 Feb; 18(1):17. PubMed ID: 30755202
[TBL] [Abstract][Full Text] [Related]
72. High-mobility group box-1 and receptor for advanced glycation end products in preterm infants with brain injury.
Lu HY; Ma JL; Shan JY; Zhang J; Wang QX; Zhang Q
World J Pediatr; 2017 Jun; 13(3):228-235. PubMed ID: 27995540
[TBL] [Abstract][Full Text] [Related]
73. AGE-RAGE Interaction Does Not Explain the Clinical Improvements after Therapeutic Fasting in Osteoarthritis.
Drinda S; Franke S; Schmidt S; Stoy K; Lehmann T; Wolf G; Neumann T
Complement Med Res; 2018; 25(3):167-172. PubMed ID: 29433120
[TBL] [Abstract][Full Text] [Related]
74. Relationship between levels of advanced glycation end products and their soluble receptor and adverse outcomes in adults with type 2 diabetes.
Thomas MC; Woodward M; Neal B; Li Q; Pickering R; Marre M; Williams B; Perkovic V; Cooper ME; Zoungas S; Chalmers J; Hillis GS;
Diabetes Care; 2015 Oct; 38(10):1891-7. PubMed ID: 26253728
[TBL] [Abstract][Full Text] [Related]
75. Action of metformin therapy against advanced glycation, oxidative stress and inflammation in type 2 diabetes patients: 3 months follow-up study.
Adeshara KA; Bangar NS; Doshi PR; Diwan A; Tupe RS
Diabetes Metab Syndr; 2020; 14(5):1449-1458. PubMed ID: 32769032
[TBL] [Abstract][Full Text] [Related]
76. Role of the Soluble Receptor for Advanced Glycation End Products (sRAGE) as a Prognostic Factor for Mortality in Hemodialysis and Peritoneal Dialysis Patients.
Dozio E; Ambrogi F; de Cal M; Vianello E; Ronco C; Corsi Romanelli MM
Mediators Inflamm; 2018; 2018():1347432. PubMed ID: 30410419
[TBL] [Abstract][Full Text] [Related]
77. Advanced glycation end products, soluble receptor for advanced glycation end products, and risk of colorectal cancer.
Jiao L; Taylor PR; Weinstein SJ; Graubard BI; Virtamo J; Albanes D; Stolzenberg-Solomon RZ
Cancer Epidemiol Biomarkers Prev; 2011 Jul; 20(7):1430-8. PubMed ID: 21527578
[TBL] [Abstract][Full Text] [Related]
78. Advanced Glycation End-Products (AGEs) and Their Soluble Receptor (sRAGE) in Women Suffering from Systemic Lupus Erythematosus (SLE).
Nowak A; Przywara-Chowaniec B; Damasiewicz-Bodzek A; Blachut D; Nowalany-Kozielska E; Tyrpień-Golder K
Cells; 2021 Dec; 10(12):. PubMed ID: 34944030
[TBL] [Abstract][Full Text] [Related]
79. Genetically Modified Circulating Levels of Advanced Glycation End-Products and Their Soluble Receptor (AGEs-RAGE Axis) with Risk and Mortality of Breast Cancer.
Peng Y; Liu F; Qiao Y; Wang P; Du H; Si C; Wang X; Chen K; Song F
Cancers (Basel); 2022 Dec; 14(24):. PubMed ID: 36551607
[TBL] [Abstract][Full Text] [Related]
80. Circulating levels of soluble receptor for advanced glycation end products and ligands of the receptor for advanced glycation end products in patients with acute liver failure.
Basta G; Del Turco S; Navarra T; Lee WM;
Liver Transpl; 2015 Jun; 21(6):847-54. PubMed ID: 25825217
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
